IR-Med to Become Fully Reporting SEC Company
12 nov. 2021 09h02 HE
|
IR-Med, Inc.
IR-Med filed an application to uplist to OTCQB New York, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME), a development stage medical device company that utilizes Infra-Red...
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
13 juil. 2021 09h05 HE
|
Neovasc, Inc.
Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs VANCOUVER and MINNEAPOLIS, July 13,...
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
10 juin 2021 09h30 HE
|
PAVmed Inc.
NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its...
PAVmed to Hold Business Update Conference Call on May 17, 2021
03 mai 2021 09h30 HE
|
PAVmed Inc.
Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
PAVmed Retires Convertible Debt
03 mars 2021 09h30 HE
|
PAVmed Inc.
NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVmed Announces Proposed Public Offering of Common Stock
22 févr. 2021 16h13 HE
|
PAVmed Inc.
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVmed to Hold Business Update Conference Call on February 22, 2021
09 févr. 2021 09h30 HE
|
PAVmed Inc.
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
08 janv. 2021 10h53 HE
|
PAVmed Inc.
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update
18 août 2020 16h14 HE
|
PAVmed Inc.
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
Neovasc Announces Partial Prepayment of Convertible Debenture
17 août 2020 09h00 HE
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”)...